News|Podcasts|October 25, 2022
Accelerating New Medicines: Innovation and Technology at Curia
Author(s)Curia
Curia is proud to partner with pharma and biotech companies to make new medicines that save lives. In order to be able to do that, Curia needs to be constantly innovating. In this podcast, you will learn from Curia’s VP of Portfolio and Sourcing, James Grabowski, about Curia’s small and large molecules most recent technologies, and capabilities.
Related Content
Trending on PharmExec
1
Redefining Obesity Success in the GLP-1 Era: Q&A with Brian Hilberdink
2
FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010
3
Pharma Funding Roudup: Kardigan Announces $400 Million Initial IPO, cAMPfield Launches with $180 million Series A
4
Additive Manufacturing's Application in Pharma and Biotech
5